Apheon Acquires Teknimed: Boosting Healthcare Global Growth
- Manon Lopez
- July 7, 2026
- NEWS
- 0 Comments
Advancy is proud to have supported Apheon, a leading European private equity firm, in its acquisition of a majority stake in Teknimed. This strategic transaction marks a major milestone in the global healthcare and medical biomaterials sector.
A Strategic Partnership for Healthcare Innovation
Teknimed stands out as a world-renowned, independent leader in the manufacturing of innovative orthopaedic bone cements and cutting-edge biomaterials. This transaction establishes a powerful synergy, pairing Apheon’s extensive strategic resources with Teknimed’s proven technical expertise.
Under the leadership of CEO Carole Léonard, a second-generation family owner, the partnership is uniquely positioned to accelerate the company’s next phase of international expansion, driving excellence and sustainable value creation in high-stakes medical markets.
Advancy’s Role in Healthcare Deal Advisory
Navigating the complex landscape of healthcare transactions requires deep sector knowledge and a rigorous analytical approach. Our dedicated team at Advancy provided critical strategic support throughout this successful acquisition.
We would like to extend our warm congratulations to the teams involved in making this transaction a success:
-
The Apheon & Teknimed teams for their shared ambition and long-term vision.
-
The Advancy expert team, including Nicolas Goninet, Thibault Reinhart, Thanh-Aï Trinh, and Rayane Beddek, for their outstanding commitment.
Looking Ahead: Sustainable Growth in Medical Biomaterials
As corporate responsibility and high-end medical quality become increasingly interconnected, this partnership highlights the growing importance of backing family-owned champions with sustainable long-term capital. We look forward to seeing this collaboration thrive, unlocking new healthcare solutions on a global scale.
Discover our expertise: Want to know more about how Advancy drives high-end strategy in Private Equity and Healthcare? Discover our expertise in Mergers and Acquisitions, or connect directly with our sector experts.
